Publications Database

Ashwood P. et al. (2008)

Decreased transforming growth factor beta1 in autism: A potential link between immune dysregulation and impairment in clinical behavioral outcomes.

Journal of Neuroimmunology

204(1), pp. 149-153

Read Abstract (New Window)

Bent S. , Hendren. R. L. (2010)

Improving the prediction of response to therapy in autism.

Neurotherapeutics

7(3), pp. 232-240

Read Abstract (New Window)

Boris M. , Goldblatt A. , Edelson S. M. (2006)

Improvement in children with autism treated with intravenous gamma globulin.

Journal of Nutritional and Environmental Medicine

15(4), 169-176

Read Abstract (New Window) Read Full (New Window)

Bradstreet J. J. et al. (2014)

Efficacy of fetal stem cell transplantation in autism spectrum disorders: an open-labeled pilot study.

Cell Transplantation

S105-12.

Read Abstract (New Window)

Brown A. C. , Mehl-Madrona L. (2011)

Autoimmune and gastrointestinal dysfunctions: does a subset of children with autism reveal a broader connection?

Expert Reviewof Gastroenterology and Hepatology

5(4), pp. 465-477.

Read Abstract (New Window)

Brown N. , Panksepp J. (2008)

Low-dose naltrexone for disease prevention and quality of life.

Medical Hypotheses

72(3), pp. 333-337

Read Abstract (New Window)

Brudnak M. A. (2001)

Application of genomeceuticals to the molecular and immunological aspects of autism.

Medical Hypotheses

57(2), pp. 186-191

Read Abstract (New Window)

Buie T. (2013)

The relationship of autism and gluten.

Clinical Therapeutics

May, 35(5), pp. 578-583.

Read Abstract (New Window)

Careaga M. , Van de Water J. , Ashwood P. (2010)

Immune dysfunction in autism: A pathway to treatment.

Neurotherapeutics

7(3), pp. 283-292

Read Abstract (New Window)

Croen L. A. et al. (2015)

The health status of adults on the autism spectrum.

Autism

October, 19(7), pp. 814-823.

Read Abstract (New Window)

Faber S. et al. (2015)

A cleanroom sleeping environment's impact on markers of oxidative stress, immune dysregulation, and behavior in children with autism spectrum disorders.

BMC Complementary and Alternative Medicine

March,

Read Abstract (New Window) Read Full (New Window)

Feingold Association of the United States (2008)

Overview [of the Feingold Diet].

Riverhead, NY: Feingold Association of the United States

Frye R. E. , Rossignol D. A. (2016)

Identification and treatment of pathophysiological comorbidities of autism spectrum disorder to achieve optimal outcomes.

Clinical Medicine Insights: Pediatrics

Read Abstract (New Window) Read Full (New Window)

Fudenberg H. (1996)

Dialysable lymphocyte extract (DLyE) in infantile onset autism: a pilot study.

Biotherapy

9(1), pp. 143-147

Read Abstract (New Window)

Gesundheit B. et al. (2015)

Therapeutic properties of mesenchymal stem cells for autism spectrum disorders.

Medical Hypotheses

March, 84(3), pp. 169-177.

Read Abstract (New Window)

Goldani A. A. et al. (2014)

Biomarkers in autism.

Frontiers in Psychiatry

Read Abstract (New Window) Read Full (New Window)

Gupta S. (2000)

Immunological treatments for autism.

Journal of Autism and Developmental Disorders

30(5), pp. 475-479

Read Abstract (New Window)

Gupta S. (1999)

Treatment of children with autism with intravenous immunoglobulin.

Journal of Child Neurology

14(3), pp. 203-205

National Institute of Health (2009)

Stem cell basics.

Bethesda: National Institute of Health

Read Full (New Window)

Heuer L. et al. (2008)

Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms.

Autism Research

pp. 275-283

Read Abstract (New Window)